Saturday, June 19, 2021 6:24:22 PM
There is no TOTAL FDA WAITING PERIOD OF 60 Days.
if your source for that is the FDA's COVID-19: Developing Drugs and Biological Products for Treatment or Prevention Guidance for Industry you'll see that 24 of its pages begin with the heading "Contains Nonbinding Recommendations".
That said, the Guidance Document makes reference to the phrase "60 days" as follows:
In a trial in severe and/or critically ill patients, examples of appropriate endpoints could be:
?All-cause mortality at an appropriate time point (e.g., at least 28 days for hospitalized noncritically ill patients,27 60 days for critically ill patients28)
?Proportion of patients alive and free of respiratory failure at an appropriate timepoint (e.g., at least 28 days for hospitalized noncritically ill patients, 60 days for critically ill patients)
?Clinical status using an ordinal scale that incorporates multiple clinical outcomes of interest (e.g., death, mechanical ventilation) ordered by their clinical importance at an appropriate time point (e.g., at least 28 days for hospitalized noncritically ill patients, 60 days for critically ill patients)29
https://www.fda.gov/media/137926/download
Recommendations are just that...they aren't requirements.
FYI "e.g" means example.
There is no WAITING PERIOD of 60 days for data release or patient follow up requirement of 60 days imposed by the FDA.
Link your source if you have one.
Meanwhile, the Primary Endpoints will be measurable some time around the 4th of July.
I'm tryin ta think but nuttin happens......Curly
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • Sep 10, 2024 11:00 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM